Net profit of Glenmark Pharmaceuticals rose 15.88% to Rs 403.21 crore in the quarter ended December 2025 as against Rs 347.96 crore during the previous quarter ended December 2024. Sales rose 17.75% to Rs 3888.00 crore in the quarter ended December 2025 as against Rs 3301.90 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 3888.00 | 3301.90 | 18 |
| OPM % | 22.37 | 18.18 | - |
| PBDT | 872.79 | 579.06 | 51 |
| PBT | 718.34 | 456.33 | 57 |
| NP | 403.21 | 347.96 | 16 |
Powered by Capital Market - Live News